Baxter Stops Medication Management R&D Efforts To Focus On FDA Seizure
This article was originally published in The Gray Sheet
Executive Summary
Baxter will halt all product development in its medication management division while it addresses design flaws with Colleague infusion pumps, seized by FDA Oct. 13